GLP-2 TRZ 30mg Peptides
Advance your studies with a peptide engineered for clarity, consistency, and dependable performance.
Primavora GLP-2 TRZ is a lyophilized peptide vial designed for controlled laboratory workflows. This research-only formulation features a GLP peptide format with a total strength of 30mg, presented in a stable lyophilized matrix to support precise handling, storage, and method development.
- Each vial contains 30mg of GLP-2 TRZ, a specialized GLP peptide investigated in preclinical and in vitro models exploring epithelial integrity, nutrient signaling pathways, and tissue-level responses under controlled conditions.
This non-edible lyophilized powder is prepared for reconstitution by qualified personnel using appropriate sterile technique. Once properly reconstituted, the solution is designed to be clear and consistent, supporting accurate measurement, aliquoting, and repeatable protocols. The format is suitable for method optimization, assay qualification, and other bench applications where reproducibility and reliable composition are essential.
Primavora prioritizes meticulous presentation and handling. Each vial is packaged to help protect integrity during transit and storage, with careful lot control to support traceability. Researchers can expect a clean profile and tightly managed specifications aligned to our internal quality requirements for identity and composition.
Quality and trust are central to the Primavora standard. Our peptides are produced and filled in the USA and undergo analytical testing for identity and purity, including HPLC and MS verification. A certificate of analysis is maintained for each lot, and every step favors consistency, transparency, and rigorous documentation so research teams can proceed with confidence.
For laboratory research only. Not for human consumption or veterinary use. Not a drug, food, or cosmetic. Handle using appropriate laboratory safety practices. Store in a controlled research environment according to your institutional guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-2 TRZ?
GLP-2 TRZ appears to be a supplier-specific name for a GLP-2-oriented research compound or analog. Because the 'TRZ' suffix is not a universal scientific naming standard, the exact structure should be confirmed from the product specification or COA. Conservative site copy should therefore describe it as a GLP-2-pathway laboratory compound.
What is GLP-2 TRZ typically studied for?
GLP-2-related compounds are usually studied for intestinal growth, mucosal integrity, nutrient-absorption physiology, and gut-repair signaling. The safest FAQ wording is to explain those GLP-2 research themes while noting that the exact behavior of this product depends on the specific analog being sold.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
